Dengue is a mosquito-borne viral disease spreading to all tropical and sub-tropical countries in the world. Dengue epidemics are becoming more widespread, extreme, and frequent as a result of changes in human ecology, demography, and globalization, as well as climate change. Early identification of disease development associated with dengue, as well as access to adequate medical treatment, decreases fatality rates to less than 1%. Thus, there is rapid rise in demand for dengue testing across the globe. Furthermore, in order to sustain the spread of dengue, doctors and global authorities across the globe are urging countries to uptake diagnostic testing and thus, the production of detection kits is likely to gain uptick. This, in turn, will drive the growth of the dengue testing market.
Adroit Market Research study on the global market for dengue testing offers a holistic view of the industry from 2020 to 2028 as forecast period, including factors such as market drivers, limitations, opportunities, threats and regulatory overview. The market has been analyzed from 2018 to 2028, with a base year estimate of 2019 and a projection from 2020 to 2028. The report covers the current status and potential characteristics of the market at both the global and the country level. Moreover, the report also assesses market competition with Porter's analysis of five strengths and places leading players on the basis of their product range, regional presence, strategic initiatives and overall sales. Prominent players in the global dengue testing market have been analyzed in depth.
The need for diagnostic test kits for dengue fever is rising immensely owing to high prevalence of dengue fever across the globe which increases the demand for early detection and treatment. For instance, according to World Health Organization (WHO), dengue fever infects around 100 to 400 million people every year.
ELISA-based tests will hold substantial share of the global dengue testing market. ELISA-based tests can identify NS1 antigens and differentiate between the four serotypes of dengue virus. Furthermore, ELISA-based kits used for dengue testing are found to have higher sensitivity and thus, are preferred diagnostic option due to their superior performance. Hospitals, laboratories, diagnostic centers carry out these diagnostic tests for detection of dengue.
Asia Pacific dominated the global dengue testing market in 2019 and is expected to witness a lucrative growth during the forecast period owing to increased burden of dengue in Southeast Asian countries. Most Asian countries are affected by severe dengue fever, which has become a leading cause of hospitalization and death among children and adults in these regions.
- key players operating in the global dengue testing market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Euroimmun AG (Perkin Elmer, Inc.), Abbott Laboratories, DiaSorin, InBios International, Inc., NovaTec Immunodiagostica GmbH, Certest Biotec S.L., OriGene Technologies and Abnova Corporation.
Key Segments of the Global Dengue Testing Market
Product Overview, 2018-2028 (USD Million)
- ELISA-based Tests
- RT-PCR based Tests
- Dengue IgG/IgM Rapid Tests
End-user Overview, 2018-2028 (USD Million)
- Diagnostic Centers
Regional Overview, 2018-2028 (USD Million)
- North America
- United Kingdom
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- South Africa
- Rest of Middle East & Africa